Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14631098 | 0.89 | CPB2 (1.00) | CPB2 | |
| SCHEMBL14631097 | 0.89 | CPB2 (1.00) | CPB2 | |
| SCHEMBL6326764 | 0.81 | CPB2 (0.59) | CPB2CPB1 | |
| SCHEMBL6335298 | 0.80 | CPB2 (0.56) | CPB2CPB1 | |
| SCHEMBL15816843 | 0.79 | CPB2 (0.61) | CPB2CPB1 | |
| SCHEMBL19143011 | 0.79 | CPB2 (0.81) | CPB2 | |
| SCHEMBL7196421 | 0.78 | CPB2 (0.65) | CPB2CPB1 | |
| SCHEMBL6326796 | 0.78 | CPB2 (0.65) | CPB2CPB1 | |
| SCHEMBL6324421 | 0.78 | CPB2 (0.62) | CPB2CPB1 | |
| SCHEMBL6326270 | 0.78 | CPB2 (0.65) | CPB2CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130022587-A1 | Cycloalkyl-Substituted Imidazole Derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-01-24 | — | — | US | disclosed |
| WO-2011115064-A1 | CYCLOALKYL-SUBSTITUTED IMIDAZOLE DERIVATIVE | 第一三共株式会社 (JP) | 2011-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130022587-A1 | Cycloalkyl-Substituted Imidazole Derivative | F7, F12, TFPI | CPB2 258/4885CPB1 276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.